Interventional Oncology: Introduction

Interventional oncology is a branch of medical science that deals with minimally invasive medical procedures carried out under image guidance by interventional radiologists for the diagnosis, treatment, and palliation of different types of cancer

Access Full Report @ https://www.transparencymarketresearch.com/interventional-oncology-market.html

In interventional oncology procedures, different image guided techniques such as computed tomography, fluoroscopy, and ultrasound are used to diagnose and treat the specific site affected with pain or cancer

The interventional oncology procedure is most commonly performed with other cancer treatments such as surgery, chemotherapy, and radiation therapy. These procedures offer several advantages such as quicker recover, shorter hospital stays, minimal side-effects, and more precise and accurate treatment as compared to other therapeutic procedures.

Key Drivers of Global Interventional Oncology Market

The global interventional oncology market is primarily driven by high prevalence and increase in incidence rates of cancer worldwide. Cancer is a leading cause of death globally, after cardiovascular diseases.

According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. Rise in cancer afflicted population is anticipated to be a key driver of the market.

Request Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60477

According to a Centers for Disease Control and Prevention (CDC) report, in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. This number is expected to reach 25.4 million by the end of 2024. Moreover, advantages of minimally invasive surgical procedures, technological advancements in interventional oncology, increased government funding for oncology procedures, etc., are estimated to fuel the interventional oncology market during the forecast period.

Embolization Procedure to be Highly Attractive Segment

In terms of procedure, the global interventional oncology market can be classified into ablation procedure, embolization procedure, and radiotherapy procedure

Embolization procedure is highly preferred across the globe due to benefits associated with the procedure, followed by the ablation procedure. Embolization is a process involving lodging of embolus within the bloodstream in order to block the blood supply to the tumor. The process involves chemical or irradiation technique for selective occlusion of blood vessels by introducing emboli. Radiotherapy is a treatment for cancer and other less common diseases such as thyroid, blood disorders, and even to restrict noncancerous cell growth. Radiotherapy is an extensively utilized technique in interventional oncology. Radiotherapy procedure involves radiation through light or heat energy. The embolization segment is projected to hold a significant market share and expand at a rapid CAGR during the forecast period.

Request For Custom Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=60477

Laser Therapy to be Highly Attractive Segment

Based on indication, the global interventional oncology market can be categorized into lung cancer, renal cancer, osteosarcoma, hepatocellular carcinoma, splenomegaly, intrahepatic cholangiocarcinoma, neuroendocrine tumor, glioblastoma multiforme, metastatic colorectal cancer, and others

The lung cancer segment is estimated to account for a prominent share of the market during the forecast period owing to the high prevalence of lung cancer

Hospitals to be Highly Lucrative Segment

Based on end-user, the global interventional oncology market can be categorized into hospitals, clinics, and ambulatory surgical centers

The hospitals segment is likely to account for a major share of the global Interventional Oncology market by 2031 due to an increase in consultation of patients in hospitals

Ask References @ https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=60477

North America to Offer Significant Opportunities in Interventional Oncology Market

In terms of region, the global Interventional Oncology market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America accounted for a major share of the global market in 2020. North America and Europe are projected to account for notable shares of the global interventional oncology market due to a large population base afflicted with chronic cancer such as hepatocellular carcinoma, lung cancer, renal cancer, and metastatic colorectal cancer, in these regions. Moreover, significant adoption of minimally invasive surgeries for the effective management of cancer, well-established healthcare infrastructure, and early adoption of technologically advanced interventional oncology products are key factors that are likely to fuel the interventional oncology market during the forecast period.

The interventional oncology market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period due to high prevalence of cancer in the highly populous countries of India and China, rapidly changing healthcare systems, various government initiatives to improve overall healthcare, and increased per capita healthcare expenditure. Moreover, increase in investments by leading global interventional oncology devices companies in the region is also likely to further boost the market in Asia Pacific during the forecast period.

Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60477

Key Players Operating in Global Interventional Oncology Market

The global interventional oncology market is semi-consolidated, with the presence of international and local players. Key players operating in the global interventional oncology market are:

Boston Scientific Corporation, Medtronic plc
Terumo Corporation
BTG plc.
AngioDynamics, Inc.
Ethicon, Inc. (Johnson & Johnson)
Merit Medical Systems, Inc.
Sirtex Medical Limited
Siemens Healthineers
Eckert & Ziegler BEBIG
Varian Medical Systems, Inc.
HealthTronics, Inc.

About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]